Trial · NCT03116347
Trial comparisons13
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 13 of 13
Download this page as JSON| Comparison | Source |
|---|---|
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Local TEAEs (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Any Related Serious TEAEs Per Infusion (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Any Severe Related Treatment-emergent Adverse Events (TEAEs) Per Infusion (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Any Adverse Reactions (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Any TEAEs (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Any Related (Causally) and/or Temporally Associated TEAEs (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Local Adverse Reaction (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Any Serious TEAEs (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Any Temporally Associated TEAEs (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Systemic TEAEs (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: deaths from any cause | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: Safety: Number of Participants With Systemic Adverse Reaction (Excluding Infections) | Trial comparisons |
| HyQvia New Starters vs HyQvia Pre-treated: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03116347/comparisons